Video Education to Improve Blood Pressure Control in Patients With Ischemic Heart Disease and Hypertension (V-EDUCATE)
NCT ID: NCT07210073
Last Updated: 2025-10-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
218 participants
INTERVENTIONAL
2024-05-27
2025-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Education Via Phone-based Text Messaging (SMS) on Patients With Uncontrolled Hypertension
NCT05711004
AI in Hypertension Treatment Education: Comparing GPT and Traditional Methods
NCT06776354
Health Literacy-Focused Program to Improve Blood Pressure Control in Korean Americans
NCT00406614
Effect of Structured Education to Decrease Blood Pressure for Hypertension in Elderly
NCT01834365
Hypertension Treatment Adherence Improving Trial
NCT04565548
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This randomized controlled trial investigates the effectiveness of a video-based educational program, developed with deepfake technology, to deliver individualized health information. Participants are randomly assigned to either the intervention group, which receives the video education in addition to usual care, or the control group, which receives usual care alone.
The primary outcomes are adherence to home blood pressure monitoring and medication adherence after one month. Secondary outcomes include changes in office and home blood pressure, as well as 24-hour ambulatory blood pressure monitoring. The results of this study may provide evidence for scalable, technology-assisted strategies to enhance adherence and improve blood pressure control in high-risk cardiovascular patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Video education
Participants receive personalized video-based education developed using deepfake technology to replicate the patient's primary physician's voice, in addition to usual care.
Video Education
Videos were created using deepfake technology, utilizing AI to replicate the voice of the patients' primary physician.
Standard Care
Participants receive standard treatment for ischemic heart disease and hypertension, without additional video-based education.
Control
Standard treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Video Education
Videos were created using deepfake technology, utilizing AI to replicate the voice of the patients' primary physician.
Control
Standard treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals who have voluntarily provided written consent to participate in this clinical trial.
Exclusion Criteria
* Individuals intolerant to all antihypertensive medications
* Patients with heart failure due to other causes, Pregnant women, those suspected of being pregnant, or those who are breastfeeding
* Patients whom the investigator deems legally or mentally unfit to participate in the clinical trial
* Patients who have participated in another clinical study involving investigational drugs within 4 weeks prior to screening.
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Keimyung University Dongsan Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Keimyung University Dongsan Hospital
Daegu, Daegu, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-02-053
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.